Current Perspectives on Epigenetic Modifications by Dietary Chemopreventive and Herbal Phytochemicals

Yue Guo, Zheng Yuan Su, Ah-Ng Kong

Research output: Contribution to journalReview article

14 Citations (Scopus)

Abstract

Studies during the last two decades have revealed the involvement of epigenetic modifications in the development of human cancer. It is now recognized that the interplay of DNA methylation, posttranslational histone modification, and non-coding RNAs can interact with genetic defects to drive tumorigenesis. The early onset, reversibility, and dynamic nature of such epigenetic modifications enable them to be developed as promising cancer biomarkers and preventive/therapeutic targets. In addition to the recent approval of several epigenetic therapies in the treatment of human cancer, emerging studies have indicated that dietary phytochemicals might exert cancer chemopreventive effects by targeting epigenetic mechanisms. In this review, we will present the current understanding of the epigenetic alterations in carcinogenesis and highlight the potential of targeting these mechanisms to treat/prevent cancer. The latest findings, published in the past 3 years regarding the effects of dietary phytochemicals in modulating epigenetic mechanisms, will also be discussed.

Original languageEnglish (US)
Pages (from-to)245-257
Number of pages13
JournalCurrent Pharmacology Reports
Volume1
Issue number4
DOIs
StatePublished - Aug 1 2015

Fingerprint

Diet Therapy
Phytochemicals
Epigenomics
Untranslated RNA
Tumor Biomarkers
Histones
Defects
Neoplasms
Carcinogenesis
Histone Code
Human Development
DNA Methylation
Post Translational Protein Processing
Therapeutics

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Genetics
  • Pharmacology
  • Drug Discovery

Keywords

  • Chemoprevention
  • Epigenetic
  • Phytochemicals

Cite this

@article{720f08a1b6174f2cb73c5b04dcfc5362,
title = "Current Perspectives on Epigenetic Modifications by Dietary Chemopreventive and Herbal Phytochemicals",
abstract = "Studies during the last two decades have revealed the involvement of epigenetic modifications in the development of human cancer. It is now recognized that the interplay of DNA methylation, posttranslational histone modification, and non-coding RNAs can interact with genetic defects to drive tumorigenesis. The early onset, reversibility, and dynamic nature of such epigenetic modifications enable them to be developed as promising cancer biomarkers and preventive/therapeutic targets. In addition to the recent approval of several epigenetic therapies in the treatment of human cancer, emerging studies have indicated that dietary phytochemicals might exert cancer chemopreventive effects by targeting epigenetic mechanisms. In this review, we will present the current understanding of the epigenetic alterations in carcinogenesis and highlight the potential of targeting these mechanisms to treat/prevent cancer. The latest findings, published in the past 3 years regarding the effects of dietary phytochemicals in modulating epigenetic mechanisms, will also be discussed.",
keywords = "Chemoprevention, Epigenetic, Phytochemicals",
author = "Yue Guo and Su, {Zheng Yuan} and Ah-Ng Kong",
year = "2015",
month = "8",
day = "1",
doi = "10.1007/s40495-015-0023-0",
language = "English (US)",
volume = "1",
pages = "245--257",
journal = "Current Pharmacology Reports",
issn = "2198-641X",
publisher = "Springer International Publishing AG",
number = "4",

}

Current Perspectives on Epigenetic Modifications by Dietary Chemopreventive and Herbal Phytochemicals. / Guo, Yue; Su, Zheng Yuan; Kong, Ah-Ng.

In: Current Pharmacology Reports, Vol. 1, No. 4, 01.08.2015, p. 245-257.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Current Perspectives on Epigenetic Modifications by Dietary Chemopreventive and Herbal Phytochemicals

AU - Guo, Yue

AU - Su, Zheng Yuan

AU - Kong, Ah-Ng

PY - 2015/8/1

Y1 - 2015/8/1

N2 - Studies during the last two decades have revealed the involvement of epigenetic modifications in the development of human cancer. It is now recognized that the interplay of DNA methylation, posttranslational histone modification, and non-coding RNAs can interact with genetic defects to drive tumorigenesis. The early onset, reversibility, and dynamic nature of such epigenetic modifications enable them to be developed as promising cancer biomarkers and preventive/therapeutic targets. In addition to the recent approval of several epigenetic therapies in the treatment of human cancer, emerging studies have indicated that dietary phytochemicals might exert cancer chemopreventive effects by targeting epigenetic mechanisms. In this review, we will present the current understanding of the epigenetic alterations in carcinogenesis and highlight the potential of targeting these mechanisms to treat/prevent cancer. The latest findings, published in the past 3 years regarding the effects of dietary phytochemicals in modulating epigenetic mechanisms, will also be discussed.

AB - Studies during the last two decades have revealed the involvement of epigenetic modifications in the development of human cancer. It is now recognized that the interplay of DNA methylation, posttranslational histone modification, and non-coding RNAs can interact with genetic defects to drive tumorigenesis. The early onset, reversibility, and dynamic nature of such epigenetic modifications enable them to be developed as promising cancer biomarkers and preventive/therapeutic targets. In addition to the recent approval of several epigenetic therapies in the treatment of human cancer, emerging studies have indicated that dietary phytochemicals might exert cancer chemopreventive effects by targeting epigenetic mechanisms. In this review, we will present the current understanding of the epigenetic alterations in carcinogenesis and highlight the potential of targeting these mechanisms to treat/prevent cancer. The latest findings, published in the past 3 years regarding the effects of dietary phytochemicals in modulating epigenetic mechanisms, will also be discussed.

KW - Chemoprevention

KW - Epigenetic

KW - Phytochemicals

UR - http://www.scopus.com/inward/record.url?scp=84994347120&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994347120&partnerID=8YFLogxK

U2 - 10.1007/s40495-015-0023-0

DO - 10.1007/s40495-015-0023-0

M3 - Review article

VL - 1

SP - 245

EP - 257

JO - Current Pharmacology Reports

JF - Current Pharmacology Reports

SN - 2198-641X

IS - 4

ER -